Compare SCNX & SYNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCNX | SYNX |
|---|---|---|
| Founded | 2010 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2M | 6.8M |
| IPO Year | 2019 | 2023 |
| Metric | SCNX | SYNX |
|---|---|---|
| Price | $0.28 | $0.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 594.3K | 36.0K |
| Earning Date | 05-13-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,831,778.00 | N/A |
| Revenue This Year | $1,097.38 | $32.35 |
| Revenue Next Year | $239.80 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 30.72 | N/A |
| 52 Week Low | $0.24 | $0.73 |
| 52 Week High | $2.60 | $1.95 |
| Indicator | SCNX | SYNX |
|---|---|---|
| Relative Strength Index (RSI) | 23.16 | N/A |
| Support Level | $0.24 | N/A |
| Resistance Level | $0.43 | N/A |
| Average True Range (ATR) | 0.02 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 0.77 | 0.00 |
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.
Silynxcom Ltd is engaged in developing, manufacturing, marketing, and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat proved. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, markets, and sells push-to-talk devices, communication controllers, and communication device cables and connectors. Geographically, it generates the majority of its revenue from Israel.